Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Marianna Giampaglia
Lapatinib, a TKI Dual Inhibitor of Her1 and Her2 Receptors: Review of the Literature
Journal of Cancer Therapy
Related publications
Lapatinib, a Dual Inhibitor of ErbB-1/-2 Receptors, Enhances Effects of Combination Chemotherapy in Bladder Cancer Cells
International Journal of Oncology
Cancer Research
Oncology
Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and Is Synergistic With Trastuzumab in Vitro and in Vivo
Clinical Cancer Research
Cancer Research
Oncology
Preclinical Antitumor Activity of BMS-599626, a Pan-Her Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling
Clinical Cancer Research
Cancer Research
Oncology
HER1/EGFR Inhibitor-Associated Rash: Future Directions for Management and Investigation Outcomes From the HER1/EGFR Inhibitor Rash Management Forum
Oncologist
Cancer Research
Medicine
Oncology
Sticky Platelet Syndrome and the Role of Glycoprotein Receptors: A Review of Literature
Journal of Blood Disorders & Transfusion
Dual-Class Firms: A Comprehensive Literature Review
Inverse Regulation of EGFR/HER1 and HER2-4 in Normal and Malignant Human Breast Tissue
PLoS ONE
Multidisciplinary
Dacomitinib (PF-00299804), an Irreversible Pan-Her Inhibitor, Inhibits Proliferation of HER2-Amplified Breast Cancer Cell Lines Resistant to Trastuzumab and Lapatinib
Molecular Cancer Therapeutics
Cancer Research
Oncology
Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma
JAMA Oncology
Cancer Research
Oncology
